Control of seizures in different stages of partial epilepsy: LACO-EXP, a Spanish retrospective study of lacosamide

Epilepsy and Behavior

Volumn 29, Issue 2, 2013, Pages 349-356

  Villanueva, Vicente ^a   López, Francisco Javier ^b   Serratosa, José María ^c   González Giraldez, Beatriz ^c   Campos, Dulce ^d   Molins, Albert ^e   Rodriguez Uranga, Juan ^f   Mauri, José Angel ^g   Salas Puig, Javier ^h   Toledo, Manuel ^h   Sánchez Alvarez, Juan Carlos ⁱ   Moreno, Antonio ^j   Serrano Castro, Pedro J ^k   Saiz Diaz, Rosa Ana ^l   González de la Aleja, Jesús ^l   de la Peña, Pilar ^l   Asensio, Montserrat ^m  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

^b HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^c HOSPITAL UNIVERSITARIO FUNDACIÓN JIMÉNEZ DÍAZ   (Spain)

^d HOSPITAL CLÍNICO UNIVERSITARIO DE VALLADOLID   (Spain)

^e HOSPITAL JOSEP TRUETA   (Spain)

^f Instituto de Especialidades Neurológicas IENSA Clinica Sagrado Corazón   (Spain)

^g HOSPITAL CLÍNICO UNIVERSITARIO LOZANO BLESA   (Spain)

^h HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

ⁱ HOSPITAL UNIVERSITARIO SAN CECILIO   (Spain)

^j HOSPITAL UNIVERSITARIO SON ESPASES   (Spain)

^k HOSPITAL TORRECÁRDENAS   (Spain)

^l HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^m HOSPITAL GENERAL UNIVERSITARIO DE ALICANTE   (Spain)

more..

Author keywords

Antiepileptic drugs; Focal epilepsy; Lacosamide; Retrospective study; Seizure free

Indexed keywords

HARKOSERIDE;

ADULT; AGED; ANTICONVULSANT THERAPY; ARTICLE; ATAXIA; BLURRED VISION; DEATH; DIZZINESS; DROWSINESS; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG MECHANISM; DRUG SAFETY; DRUG WITHDRAWAL; FEMALE; FOCAL EPILEPSY; GASTROINTESTINAL SYMPTOM; HUMAN; IRRITABILITY; MAJOR CLINICAL STUDY; MALE; MEMORY DISORDER; MULTICENTER STUDY; OBSERVATIONAL STUDY; RETROSPECTIVE STUDY; SEIZURE; SIDE EFFECT; SKIN MANIFESTATION;

ANTIEPILEPTIC DRUGS; FOCAL EPILEPSY; LACOSAMIDE; RETROSPECTIVE STUDY; SEIZURE-FREE;

ACETAMIDES; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTICONVULSANTS; EPILEPSIES, PARTIAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; OBSERVATION; RETROSPECTIVE STUDIES; SPAIN; STATISTICS, NONPARAMETRIC; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84885062506     PISSN: 15255050     EISSN: 15255069     Source Type: Journal    
DOI: 10.1016/j.yebeh.2013.07.024     Document Type: Article

References (28)

1. Kwan P., Brodie M.J. Early identification of refractory epilepsy. N Engl J Med 2000, 342(5):314-319. 10.1056/NEJM200002033420503.
2. Picot M.C., Baldy-Moulinier M., Daures J.P. The prevalence of epilepsy and pharmacoresistant epilepsy in adults: a population-based study in a Western European country. Epilepsia 2008, 49(7):1230-1238. 10.1111/j.1528-1167.2008.01579.x.
3. Ramos-Lizana J., Rodriguez-Lucenilla M.I., Aguilera-Lopez P. A study of drug-resistant childhood epilepsy testing the new ILAE criteria. Seizure 2012, 21(4):266-272. 10.1016/j.seizure.2012.01.009.
4. Kwan P., Arzimanoglou A., Berg A.T., et al. Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies. Epilepsia 2010, 51(6):1069-1077. 10.1111/j.1528-1167.2009.02397.x.
5. Luciano A.L., Shorvon S.D. Results of treatment changes in patients with apparently drug-resistant chronic epilepsy. Ann Neurol 2007, 62(4):375-381. 10.1002/ana.21064.
6. Neligan A., Bell G.S., Elsayed M., et al. Treatment changes in a cohort of people with apparently drug-resistant epilepsy: an extended follow-up. J Neurol Neurosurg Psychiatry 2012, 83(8):810-813. 10.1136/jnnp-2011-302085.
7. Schiller Y., Najjar Y. Quantifying the response to antiepileptic drugs: effect of past treatment history. Neurology 2008, 70(1):54-65. 10.1212/01.wnl.0000286959.22040.6e.
8. Brodie M.J., Sills G.J. Combining antiepileptic drugs-rational polytherapy?. Seizure 2011, 20(5):369-375. 10.1016/j.seizure.2011.01.004.
9. Stephen L.J., Forsyth M., Kelly K., Brodie M.J. Antiepileptic drug combinations-have newer agents altered clinical outcomes?. Epilepsy Res 2012, 98(2-3):194-198. 10.1016/j.eplepsyres.2011.09.008.
10. Ben-Menachem E., Biton V., Jatuzis D., Abou-Khalil B., Doty P., Rudd G.D. Efficacy and safety of oral lacosamide as adjunctive therapy in adults with partial-onset seizures. Epilepsia 2007, 48(7):1308-1317. 10.1111/j.1528-1167.2007.01188.x.
11. Chung S., Sperling M.R., Biton V., et al. Lacosamide as adjunctive therapy for partial-onset seizures: a randomized controlled trial. Epilepsia 2010, 51(6):958-967. 10.1111/j.1528-1167.2009.02496.x.
12. Halasz P., Kalviainen R., Mazurkiewicz-Beldzinska M., et al. Adjunctive lacosamide for partial-onset seizures: efficacy and safety results from a randomized controlled trial. Epilepsia 2009, 50(3):443-453. 10.1111/j.1528-1167.2008.01951.x.
13. Casas-Fernandez C., Martinez-Bermejo A., Rufo-Campos M., Smeyers-Durá P., Herranz-Fernández J.L., Ibáñez-Micó S., et al. Efficacy and tolerability of lacosamide in the concomitant treatment of 130 patients under 16years of age with refractory epilepsy: a prospective, open-label, observational, multicenter study in Spain. Drugs R&D 2012, 12(4):187-197. 10.2165/11636260-000000000-00000.
14. Flores L., Kemp S., Colbeck K., et al. Clinical experience with oral lacosamide as adjunctive therapy in adult patients with uncontrolled epilepsy: a multicentre study in epilepsy clinics in the United Kingdom (UK). Seizure 2012, 21(7):512-517. 10.1016/j.seizure.2012.05.005.
15. Garcia-Morales I., Delgado R.T., Falip M., Campos D., García M.E., Gil-Nagel A. Early clinical experience with lacosamide as adjunctive therapy in patients with refractory focal epilepsy and nocturnal seizures. Seizure 2011, 20(10):801-804. 10.1016/j.seizure.2011.08.005.
16. Harden C.L., Cohn A., Lowe M., Serrano E. Initial post marketing experience with lacosamide in adult patients with epilepsy. Epilepsy Res 2012, 98(2-3):260-263. 10.1016/j.eplepsyres.2011.09.010.
17. Stephen L.J., Kelly K., Parker P., Brodie M.J. Adjunctive lacosamide in clinical practice: sodium blockade with a difference?. Epilepsy Behav 2011, 22(3):499-504. 10.1016/j.yebeh.2011.07.035.
18. Villanueva V., Lopez-Gomariz E., Lopez-Trigo J., Palau J., Garcia M., Villaroya T., et al. Rational polytherapy with lacosamide in clinical practice: results of a Spanish cohort analysis RELACOVA. Epilepsy Behav 2012, 23(3):298-304. 10.1016/j.yebeh.2011.11.026.
19. Wehner T., Bauer S., Hamer H.M., et al. Six months of postmarketing experience with adjunctive lacosamide in patients with pharmacoresistant focal epilepsy at a tertiary epilepsy center in Germany. Epilepsy Behav 2009, 16(3):423-425. 10.1016/j.yebeh.2009.07.043.
20. Yorns W.R., Khurana D.S., Carvalho K.S., et al. Efficacy of lacosamide as adjunctive therapy in children with refractory epilepsy. J Child Neurol 2012, 10.1177/0883073812462887.
21. Proposal for revised clinical and electroencephalographic classification of epileptic seizures. From the Commission on Classification and Terminology of the International League Against Epilepsy. Epilepsia 1981, 22(4):489-501.
22. European Medicines Agency Vimpat: Ficha Técnica O Resumen De Las Características Del Producto [in Spanish] Available from URL:, [Accessed 2 Aug 2011]. http://www.ema.europa.eu/docs/es_ES/document_library/EPAR_-_Product_Information/human/000863/WC500050338.pdf.
23. Kamel J.T., Degruyter M.A., D'Souza W.J., Cook M.J. Clinical experience with using lacosamide for the treatment of epilepsy in a tertiary centre. Acta Neurol Scand 2013, 127(3):149-153. 10.1111/j.1600-0404.2012.01704.x.
24. Kamel J.T., Degruyter M.A., D'Souza W.J., Cook M.J. Clinical experience with using lacosamide for the treatment of epilepsy in a tertiary centre. Acta Neurol Scand 2013, 127(3):149-153. 10.1111/j.1600-0404.2012.01704.x.
25. Knoester P.D., Keyser A., Renier W.O., Egberts A.C.G., Hekster Y.A., Deckers C.L.P. Effectiveness of lamotrigine in clinical practice: results of a retrospective population-based study. Epilepsy Res 2005, 65(1-2):93-100. 10.1016/j.eplepsyres.2005.05.005.
26. Zaccara G., Perucca P., Loiacono G., et al. The adverse event profile of lacosamide: a systematic review and meta-analysis of randomized controlled trials. Epilepsia 2013, 54(1):66-74. 10.1111/j.1528-1167.2012.03589.x.
27. Sake J.-K., Hebert D., Isojarvi J., et al. A pooled analysis of lacosamide clinical trial data grouped by mechanism of action of concomitant antiepileptic drugs. CNS Drugs 2010, 24(12):1055-1068. 10.2165/11587550-000000000-00000.
28. Noack-Rink M., Mayer T., Arnold S., et al. Lacosamide as add-on to monotherapy in patients with partial-onset seizures: interim results of the post-marketing Vitoba study (Vimpat added to one baseline AED) [poster 639]. European Congress on Epileptology; London, UK 2012.